Rintala, Jukka M <br/><br/>
Oral Platelet-Derived Growth Factor and Vascular Endothelial Growth Factor Inhibitor Sunitinib Prevents Chronic Allograft Injury in Experimental Kidney Transplantation Model.  [electronic resource] 

 -  Transplantation  Jan 2016 
 - 103-10 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1534-6080 
<br/><br/><label>Standard No.: </label>10.1097/TP.0000000000000837  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Allografts<br/>Animals<br/>Cell Movement--drug effects<br/>Cell Proliferation--drug effects<br/>Cells, Cultured<br/>Chronic Disease<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Graft Rejection--enzymology<br/>Indoles--administration & dosage<br/>Kidney--drug effects<br/>Kidney Transplantation--adverse effects<br/>Male<br/>Muscle, Smooth, Vascular--drug effects<br/>Myocytes, Smooth Muscle--drug effects<br/>Neointima<br/>Platelet-Derived Growth Factor--antagonists & inhibitors<br/>Protein Kinase Inhibitors--administration & dosage<br/>Proto-Oncogene Proteins c-sis--antagonists & inhibitors<br/>Pyrroles--administration & dosage<br/>Rats, Wistar<br/>Signal Transduction--drug effects<br/>Sunitinib<br/>Time Factors<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Vascular Endothelial Growth Factor B--antagonists & inhibitors<br/>Vascular Endothelial Growth Factors--antagonists & inhibitors